Aquestive Therapeutics, Inc. Common Stock
AQST
AQST: Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
moreShow AQST Financials
Recent trades of AQST by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by AQST's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Oral film compositions and dosage forms having precise active dissolution profiles Jan. 03, 2023
-
Patent Title: Pharmaceutical compositions with enhanced permeation Mar. 15, 2022
-
Patent Title: Process for manufacturing a resulting pharmaceutical film Dec. 28, 2021
-
Patent Title: Enhanced delivery epinephrine compositions Dec. 07, 2021
-
Patent Title: Enhanced delivery epinephrine compositions Nov. 02, 2021
-
Patent Title: Dual lane coating Sep. 28, 2021
-
Patent Title: Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions Aug. 03, 2021
-
Patent Title: Reduction in stress cracking of films Mar. 16, 2021
-
Patent Title: Manufacturing of small film strips Mar. 09, 2021
-
Patent Title: Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom Jan. 12, 2021
-
Patent Title: Sublingual and buccal film compositions Nov. 03, 2020
-
Patent Title: Process for manufacturing a resulting pharmaceutical film Aug. 04, 2020
-
Patent Title: Reduction in stress cracking of films Nov. 05, 2019
-
Patent Title: Manufacturing of small film strips Apr. 30, 2019
-
Patent Title: Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom Oct. 30, 2018
-
Patent Title: Sublingual and buccal film compositions Jul. 31, 2018
Federal grants, loans, and purchases
Followers on AQST's company Twitter account
Number of mentions of AQST in WallStreetBets Daily Discussion
Recent insights relating to AQST
Recent picks made for AQST stock on CNBC
ETFs with the largest estimated holdings in AQST
Flights by private jets registered to AQST